#######################
# Document Properties #
#######################
SET DOCUMENT Copyright   = "Copyright © 2018 Fraunhofer Institute SCAI, All rights reserved."
SET DOCUMENT Licenses    = "CC BY 4.0"
SET DOCUMENT ContactInfo = "charles.hoyt@scai.fraunhofer.de"

SET DOCUMENT Name        = "Alzheimer's Disease: Targeting the Cholinergic System"
SET DOCUMENT Version     = "1.0.0"
SET DOCUMENT Authors     = "Sandra Spalek"
SET DOCUMENT Description = ""

##############
# Namespaces #
##############

# Namespaces hosted on https://github.com/pharmacome/terminology
# --------------------------------------------------------------
DEFINE NAMESPACE CHEBI          AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/chebi-names.belns"
DEFINE NAMESPACE DRUGBANK       AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/drugbank-names.belns"
DEFINE NAMESPACE ECCODE         AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/ec-code.belns"
# DEFINE NAMESPACE FB           AS URL "https://raw.githubusercontent.com/pharmacome/terminology/80171ae62cf43aa1fc8a6c326b94537ab342458c/external/fb-names.belns"
DEFINE NAMESPACE CONSO          AS URL "https://raw.githubusercontent.com/pharmacome/conso/501ceccdc9a27d97edbdc48a89ebe8e1dd3626e9/export/conso-names.belns"
DEFINE NAMESPACE HGNC           AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/hgnc-names.belns"
DEFINE NAMESPACE HGNCGENEFAMILY AS URL "https://raw.githubusercontent.com/pharmacome/terminology/3074b85b858455d8eeb76cfcdef685ced19bbe11/external/hgnc.genefamily-names.belns"
DEFINE NAMESPACE GO             AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/go-names.belns"
DEFINE NAMESPACE INTERPRO       AS URL "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/interpro-names.belns"
DEFINE NAMESPACE MESH           AS URL "https://raw.githubusercontent.com/pharmacome/terminology/8ccfed235e418e4c8aa576f9a5ef0f838e794c7f/external/mesh-names.belns"
DEFINE NAMESPACE MGI            AS URL "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/mgi-names.belns"
DEFINE NAMESPACE NCBIGENE       AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/entrez.belns"
DEFINE NAMESPACE PFAM           AS URL "https://raw.githubusercontent.com/pharmacome/terminology/8ccfed235e418e4c8aa576f9a5ef0f838e794c7f/external/pfam-names.belns"
DEFINE NAMESPACE RGD            AS URL "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/rgd-names.belns"

# Namespaces hosted on https://github.com/sorgerlab/famplex
# ---------------------------------------------------------
DEFINE NAMESPACE FPLX           AS URL "https://raw.githubusercontent.com/sorgerlab/famplex/e8ae9926ff95266032cb74f77973c84939bffbeb/export/famplex.belns"

# Namespaces hosted on https://arty.scai.fraunhofer.de/artifactory/bel/namespace
# ------------------------------------------------------------------------------
DEFINE NAMESPACE HP             AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hp/hp-20171108.belns"

# Namespaces defined with regular expressions
# -------------------------------------------
DEFINE NAMESPACE DBSNP          AS PATTERN "rs[0-9]+"
DEFINE NAMESPACE TAXONOMY       AS PATTERN "^\d+$"
DEFINE NAMESPACE UNIPROT        AS PATTERN "^([A-N,R-Z][0-9]([A-Z][A-Z, 0-9][A-Z, 0-9][0-9]){1,2})|([O,P,Q][0-9][A-Z, 0-9][A-Z, 0-9][A-Z, 0-9][0-9])(\.\d+)?$"
DEFINE NAMESPACE PUBCHEM        AS PATTERN "^\d+$"

###############
# Annotations #
###############

# Annotations defined with regular expressions
# --------------------------------------------
DEFINE ANNOTATION Species       AS PATTERN "^\d+$"

# Annotations hosted on https://arty.scai.fraunhofer.de/artifactory/bel/annotation
# --------------------------------------------------------------------------------
DEFINE ANNOTATION Anatomy       AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno"
DEFINE ANNOTATION CellLine      AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno"
DEFINE ANNOTATION CellStructure AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno"
DEFINE ANNOTATION Cell          AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno"
DEFINE ANNOTATION Confidence    AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno"
DEFINE ANNOTATION Disease       AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20170511.belanno"
DEFINE ANNOTATION MeSHAnatomy   AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno"
DEFINE ANNOTATION MeSHDisease   AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno"
DEFINE ANNOTATION Subgraph      AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/neurommsig/neurommsig-1.0.3.belanno"
DEFINE ANNOTATION TextLocation  AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/text-location/text-location-1.0.1.belanno"

##############
# Statements #
##############
SET Citation = {"PubMed", "26813123"}

SET Evidence = "Acetylcholine (ACh) was the first neurotransmitter to be identified"
SET Confidence = "High"
a(CHEBI:acetylcholine) isA a(CHEBI:neurotransmitter)
UNSET Confidence

SET Evidence = "Given its widespread distribution in the brain, it is not
surprising that cholinergic neurotransmission is responsible
for modulating important neural functions"
SET Confidence = "High"
bp(GO:"synaptic transmission, cholinergic") reg act(a(MESH:Neurons))
UNSET Confidence

SET Evidence = "The cholinergic system is involved in critical physiological processes, such
as attention, learning, memory, stress response, wakefulness and sleep, and sensory information"
SET Confidence = "High"
bp(GO:"synaptic transmission, cholinergic") -- path(MESH:Attention)
bp(GO:"synaptic transmission, cholinergic") -- bp(GO:learning)
bp(GO:"synaptic transmission, cholinergic") -- bp(GO:memory)
bp(GO:"synaptic transmission, cholinergic") -- bp(GO:"response to stress")
bp(GO:"synaptic transmission, cholinergic") -- bp(GO:"regulation of circadian sleep/wake cycle, wakefulness")
bp(GO:"synaptic transmission, cholinergic") -- bp(GO:"regulation of circadian sleep/wake cycle, sleep")
bp(GO:"synaptic transmission, cholinergic") -- bp(GO:"sensory processing")
UNSET Confidence

SET Evidence = "Experimental data using non-human primates and rodents have demonstrated that
injuries introduced to basal forebrain cholinergic neurons that innervate the cortex lead to attention deficit"
SET Confidence = "High"
SET MeSHAnatomy = "Basal Forebrain"
act(a(MESH:"Cholinergic Neurons")) -> path(MESH:Attention)
UNSET MeSHAnatomy
UNSET Confidence

SET Evidence = "On the other hand, the facilitation of the cholinergic
transmission by using the cholinesterase inhibitors can improve attention in humans"
SET Confidence = "Medium"
a(CHEBI:"EC 3.1.1.7 (acetylcholinesterase) inhibitor") -> bp(GO:"synaptic transmission, cholinergic")
#above Statement was added according to evidence
bp(GO:"synaptic transmission, cholinergic") -> path(MESH:Attention)
UNSET Confidence

SET Evidence = "It has been demonstrated that the cholinergic system
plays a role in the learning process"
SET Confidence = "High"
bp(GO:"synaptic transmission, cholinergic") positiveCorrelation bp(GO:learning)
UNSET Confidence

SET Evidence = "Moreover, published data indicate that ACh is involved in memory"
SET Confidence = "High"
a(CHEBI:acetylcholine) positiveCorrelation bp(GO:memory)
UNSET Confidence

SET Evidence = "Further studies have demonstrated that endogenous
acetylcholine is important for modulation of acquisition [17],
encoding [18], consolidation [19], reconsolidation [20],
extinction [21] and retrieval of memory"
SET Confidence = "High"
a(CHEBI:acetylcholine) reg bp(GO:memory)
UNSET Confidence

SET Evidence = "The importance of the cholinergic neurons from the nucleus basalis of
Meynert on memory is highlighted by the fact that the specific degeneration of these
neurons takes place in Alzheimer’s disease (AD) and contributes to the memory
loss exhibited by AD patients"
SET Confidence = "High"
SET MeSHAnatomy = "Basal Nucleus of Meynert"
a(MESH:"Cholinergic Neurons") positiveCorrelation bp(GO:memory)
UNSET MeSHAnatomy
SET MeSHDisease = "Alzheimer Disease"
path(CONSO:"Neurodegeneration") negativeCorrelation bp(GO:memory)
UNSET MeSHDisease
UNSET Confidence

SET Evidence = "Stress is another factor that can regulate ACh release in
the forebrain and its function on the hypothalamic-pituitaryadrenal
(HPA) system can modulate biological and emotional outcomes"
SET Confidence = "High"
bp(GO:"response to stress") reg tloc(a(CHEBI:acetylcholine),fromLoc(GO:intracellular),toLoc(MESH:"Basal Forebrain"))
a(CHEBI:acetylcholine) reg a(MESH:"Hypothalamo-Hypophyseal System")
UNSET Confidence

SET Evidence = "In a work that evaluated the
function of the cholinergic system in mediating the response
to stress it was found that treatment of rats with the antagonist
of the nicotinic receptor, mecamylamine, attenuates the
activation of the HPA axis in response to a stressor agent"
SET Confidence = "High"
SET Species = "10116"
a(MESH:"Receptors, Nicotinic") -> act(a(MESH:"Hypothalamo-Hypophyseal System"))
a(CHEBI:Mecamylamine) -| act(a(MESH:"Hypothalamo-Hypophyseal System"))
UNSET Species
UNSET Confidence

SET Evidence = "Similarly, nicotine can mimic the ACh effects on the
HPA axis by activating nicotinic receptors"
SET Confidence = "High"
a(CHEBI:nicotine) -> act(a(MESH:"Receptors, Nicotinic"))
a(CHEBI:acetylcholine) -> act(a(MESH:"Receptors, Nicotinic"))
UNSET Confidence

SET Evidence = "Another important function of the cholinergic system is
to regulate the sleep cycle"
SET Confidence = "High"
bp(GO:"synaptic transmission, cholinergic") reg bp(GO:"circadian sleep/wake cycle")
UNSET Confidence

SET Evidence = "It has been demonstrated that
stimulation of cholinergic neurons in precise regions of the
brainstem can promote REM (rapid eye movement) sleep, dose-dependently"
SET Confidence = "High"
SET MeSHAnatomy = "Brain Stem"
a(MESH:"Cholinergic Neurons") -> bp(GO:"circadian sleep/wake cycle, REM sleep")
UNSET MeSHAnatomy
UNSET Confidence

SET Evidence = "ACh contributes to auditory synaptic transmission by facilitating thalamocortical communication"
SET Confidence = "Medium"
a(CHEBI:acetylcholine) -> bp(GO:"response to auditory stimulus")
#response to auditory stimulus looked apt hence added
a(CHEBI:acetylcholine) -> bp(GO:"synaptic transmission, cholinergic")
UNSET Confidence

SET Evidence = "Recent evidences also suggest the involvement
of ACh in adult neurogenesis"
SET Confidence = "High"
a(CHEBI:acetylcholine) -> bp(GO:neurogenesis)
UNSET Confidence

SET Evidence = "ACh synthesis takes place in the cytoplasm of cholinergic neurons"
SET Confidence = "High"
SET MeSHAnatomy = "Cytoplasm"
a(MESH:"Cholinergic Neurons") -> a(CHEBI:acetylcholine)
UNSET MeSHAnatomy
UNSET Confidence

SET Evidence = "The enzyme choline acetyltransferase (ChAT) can
synthesize ACh from choline and acetyl-coenzyme A (acetyl-CoA)"
SET Confidence = "High"
p(HGNC:CHAT) -> rxn(reactants(a(CHEBI:choline),a(CHEBI:"acetyl-CoA")),products(a(CHEBI:acetylcholine)))
UNSET Confidence

SET Evidence = "Following that, the neurotransmitter is
transported by the vesicular acetylcholine transporter
(VAChT) from the cytosol into synaptic vesicles"
SET Confidence = "High"
#the neurotransmitter: ACh
p(HGNC:SLC18A3) -> tloc(a(CHEBI:acetylcholine),fromLoc(GO:cytosol),toLoc(MESH:"Synaptic Vesicles"))
UNSET Confidence

SET Evidence = "Although cholinergic neurons
can synthesize choline, the de novo synthesis contributes
only with a very small fraction of the total choline that is
needed for ACh synthesis (see Fig. 1)"
SET Confidence = "High"
a(MESH:"Cholinergic Neurons") -> a(CHEBI:choline)
UNSET Confidence

SET Evidence = "ChAT activity is regulated by neuronal depolarization,
influx of Ca2+ and phosphorylation of the enzyme by a wide variety of protein kinases"
SET Confidence = "High"
SET MeSHAnatomy = "Neurons"
bp(GO:"membrane depolarization") reg act(p(HGNC:CHAT))
UNSET MeSHAnatomy
bp(GO:"calcium ion import") reg act(p(HGNC:CHAT))
p(HGNC:CHAT,pmod(Ph)) reg act(p(HGNC:CHAT))
UNSET Confidence

SET Evidence = "Each molecule of ACh transported
by VAChT is in exchange for two vesicular protons,
which leads to the fulfill of synaptic vesicles with the neurotransmitter"
SET Confidence = "High"
p(HGNC:SLC18A3) -> tloc(a(CHEBI:acetylcholine),fromLoc(GO:cytosol),toLoc(MESH:"Synaptic Vesicles"))
p(HGNC:SLC18A3) -> tloc(a(CHEBI:proton),fromLoc(MESH:"Synaptic Vesicles"),toLoc(GO:cytosol))
UNSET Confidence

SET Evidence = "The vesicular transporter activity
can be blocked by vesamicol, which is a non-competitive inhibitor"
SET Confidence = "High"
a(CHEBI:"2-(4-phenyl-1-piperidinyl)-1-cyclohexanol") -| act(p(HGNC:SLC18A3))
a(CHEBI:"2-(4-phenyl-1-piperidinyl)-1-cyclohexanol") -|  tloc(a(CHEBI:acetylcholine),fromLoc(GO:cytosol),toLoc(MESH:"Synaptic Vesicles"))
UNSET Confidence

SET Evidence = "Interestingly, PKC can
phosphorylate VAChT and regulate its vesicular localization"
SET Confidence = "High"
p(FPLX:PKC) -> p(HGNC:SLC18A3,pmod(Ph))
UNSET Confidence

SET Evidence = "A VAChT knockdown mouse model, expressing
about 68% less VAChT protein, shows major neuromuscular deficits"
SET Confidence = "Medium"
SET Species = "10090"
p(MGI:Slc18a3) -| path(MESH:"Neuromuscular Diseases")
#species was considerable from the current evidence to the next one
UNSET Confidence

SET Evidence = "Furthermore, cognitive impairment can take place even due to a mild
decrease in VAChT protein expression (about 45%)"
SET Confidence = "High"
p(MGI:Slc18a3) -> bp(GO:cognition)
UNSET Species
UNSET Confidence

SET Evidence = "When cholinergic neurons are depolarized, ACh is
exocytosed from synaptic vesicles and released into the
synaptic cleft, where it can activate both muscarinic and nicotinic receptors"
SET Confidence = "High"
SET Cell = "cholinergic neuron"
bp(GO:"membrane depolarization") -> tloc(a(CHEBI:acetylcholine),fromLoc(MESH:"Synaptic Vesicles"),toLoc(GO:"synaptic cleft"))
UNSET Cell
# in the synaptic cleft
a(CHEBI:acetylcholine) -> act(p(FPLX:CHRM))
a(CHEBI:acetylcholine) -> act(p(FPLX:CHRN))
UNSET Confidence

SET Evidence = "ACh present at the synaptic cleft is
rapidly inactivated by the enzyme acetylcholinesterase
(AChE), releasing choline and acetate"
SET Confidence = "High"
# in the synaptic cleft
p(HGNC:ACHE) -| act(a(CHEBI:acetylcholine))
p(HGNC:ACHE) -> rxn(reactants(a(CHEBI:acetylcholine)),products(a(CHEBI:choline),a(CHEBI:acetate)))
UNSET Confidence

SET Evidence = "Cholinergic neurons secrete AChE into the synaptic cleft, where the
enzyme is normally associated with the plasma membrane (see Fig. 1)"
SET Confidence = "High"
a(MESH:"Cholinergic Neurons") -> tloc(p(HGNC:ACHE),fromLoc(MESH:"Synaptic Vesicles"),toLoc(GO:"synaptic cleft"))
UNSET Confidence

SET Evidence = "The organophosphate compounds are irreversible
AChE inhibitors that are used as insecticides and nerve gases"
SET Confidence = "High"
a(CHEBI:"organophosphorus compound") -| act(p(HGNC:ACHE))
UNSET Confidence

SET Evidence = "Thus, antidotes, including doxylamine, can be used to
speed enzyme regeneration"
SET Confidence = "High"
# regeneration of ACHE
a(CHEBI:antidote) -> act(p(HGNC:ACHE))
a(CHEBI:doxylamine) -> act(p(HGNC:ACHE))
UNSET Confidence

SET Evidence = "Moreover, AChE inhibitors
that compete for the enzyme site, as succinylcholine, are
used as anesthetic adjuvants since these drugs can promote
neuromuscular blockage"
SET Confidence = "High"
a(CHEBI:succinylcholine) -| act(p(HGNC:ACHE))
UNSET Confidence

SET Evidence = "Choline that is released by ACh hydrolysis in the
synaptic cleft is continuously reuptaken into the presynaptic
cholinergic neuron by an active transport system (see Fig. 1)"
SET Confidence = "High"
# active transport system: SLC5A7
deg(a(CHEBI:acetylcholine)) -> a(CHEBI:choline)
p(HGNC:SLC5A7) -> tloc(a(CHEBI:choline),fromLoc(GO:"synaptic cleft"),toLoc(MESH:"Cholinergic Neurons"))
UNSET Confidence

SET Evidence = "Two choline transporters have been identified in
neurons: a ubiquitous, low-affinity, sodium-independent
transporter that can only be inhibited by high concentrations
of hemicholinium-3 (HC-3) (Ki of about 50 μM), and a highaffinity,
sodium-dependent, HC-3-sensitive (Ki of 10-100
nM) choline transporter (CHT1)"
SET Confidence = "High"
p(HGNC:SLC5A7) -> tloc(a(CHEBI:choline),fromLoc(GO:"synaptic cleft"),toLoc(MESH:"Cholinergic Neurons"))
UNSET Confidence

SET Evidence = "CHT1 is mainly found in cholinergic neurons [92-94] and is
responsible for supplying choline for the synthesis of ACh"
SET Confidence = "High"
SET Cell = "cholinergic neuron"
p(HGNC:SLC5A7) -> a(CHEBI:choline)
a(CHEBI:choline) -> a(CHEBI:acetylcholine)
UNSET Cell
UNSET Confidence

SET Evidence = "Moreover, mice that display a
disruption of CHT1 gene expression exhibit symptoms
related to ACh deficit and inevitable death within an hour of birth"
SET Confidence = "High"
SET Species = "10090"
p(MGI:Slc5a7) -| path(MESH:Death)
UNSET Species
UNSET Confidence

SET Evidence = "Interestingly, it has been demonstrated that an increase in
neuronal firing can lead to an increase in choline uptake and in the synthesis of ACh"
SET Confidence = "High"
bp(GO:"action potential initiation") -> tloc(a(CHEBI:choline),fromLoc(GO:"extracellular region"),toLoc(GO:intracellular))
bp(GO:"action potential initiation") -> a(CHEBI:acetylcholine)
UNSET Confidence

SET Evidence = "It is possible that the presence of CHT1 in the membrane of synaptic
vesicles and the consequent increase in CHT1 relocation to
the plasma membrane following neuronal depolarization
could explain why an increase in neuronal firing promotes
increased choline reuptake and, thus, ACh synthesis"
SET Confidence = "High"
SET MeSHAnatomy = {"Synaptic Vesicles","Membranes"}
p(HGNC:SLC5A7) -> tloc(a(CHEBI:choline),fromLoc(GO:"synaptic cleft"),toLoc(MESH:"Cholinergic Neurons"))
p(HGNC:SLC5A7) -> a(CHEBI:acetylcholine)
bp(GO:"action potential initiation") -> tloc(a(CHEBI:choline),fromLoc(GO:"synaptic cleft"),toLoc(MESH:"Cholinergic Neurons"))
bp(GO:"action potential initiation") -> a(CHEBI:acetylcholine)
UNSET MeSHAnatomy

SET MeSHAnatomy = "Neurons"
bp(GO:"membrane depolarization") -> complex(p(HGNC:SLC5A7),a(GO:"plasma membrane"))
complex(p(HGNC:SLC5A7),a(GO:"plasma membrane")) -- bp(GO:"action potential initiation")
UNSET MeSHAnatomy
UNSET Confidence

SET Evidence = "Importantly, the neurons that form the nucleus basalis of
Meynert undergo extensive degeneration in AD"
SET Confidence = "High"
path(MESH:"Alzheimer Disease") -> deg(a(MESH:"Basal Nucleus of Meynert"))
UNSET Confidence

SET Evidence = "Nicotinic receptors are formed by five different
subunits: α, β, δ, and γ (fetal) or ε (adult)"
SET Confidence = "High"
p(HGNC:CHRND) -> a(MESH:"Receptors, Nicotinic")
p(HGNC:CHRNE) -> a(MESH:"Receptors, Nicotinic")
p(HGNC:CHRNG) -> a(MESH:"Receptors, Nicotinic")
p(HGNC:CHRNB1) -> a(MESH:"Receptors, Nicotinic")
p(HGNC:CHRNA1) -> a(MESH:"Receptors, Nicotinic")
UNSET Confidence

SET Evidence = "Cholinergic nicotinic receptors expressed
in muscle and ganglia are comprised of two α subunits plus
each of the other three"
SET Confidence = "High"
SET MeSHAnatomy = {"Muscles","Ganglia"}
complex(p(HGNC:CHRNA1),p(HGNC:CHRNA1),p(HGNC:CHRNB1),p(HGNC:CHRNG),p(HGNC:CHRND)) -> p(FPLX:CHRN)
UNSET MeSHAnatomy
UNSET Confidence

SET Evidence = "On the other hand, neuronal nicotinic
receptors are formed by the combination of only two types of
subunits (α2-10 and β2-4)"
SET Confidence = "High"
SET MeSHAnatomy = "Neurons"
p(HGNC:CHRNA2) -> a(MESH:"Receptors, Nicotinic")
p(HGNC:CHRNA3) -> a(MESH:"Receptors, Nicotinic")
p(HGNC:CHRNA4) -> a(MESH:"Receptors, Nicotinic")
p(HGNC:CHRNA5) -> a(MESH:"Receptors, Nicotinic")
p(HGNC:CHRNA6) -> a(MESH:"Receptors, Nicotinic")
p(HGNC:CHRNA7) -> a(MESH:"Receptors, Nicotinic")
p(HGNC:CHRNA9) -> a(MESH:"Receptors, Nicotinic")
p(HGNC:CHRNA10) -> a(MESH:"Receptors, Nicotinic")
p(HGNC:CHRNB2) -> a(MESH:"Receptors, Nicotinic")
p(HGNC:CHRNB3) -> a(MESH:"Receptors, Nicotinic")
p(HGNC:CHRNB4) -> a(MESH:"Receptors, Nicotinic")
UNSET MeSHAnatomy
UNSET Confidence

SET Evidence = "In the peripheral nervous system, activation of nicotinic
receptors leads to rapid synaptic transmission"
SET Confidence = "High"
SET MeSHAnatomy = "Peripheral Nervous System"
act(a(MESH:"Receptors, Nicotinic")) -> bp(MESH:"Synaptic Transmission")
UNSET MeSHAnatomy
UNSET Confidence

SET Evidence = "In the CNS, most of the nicotinic receptors are expressed at the
presynaptic neuronal membrane and their main role is to
regulate the release of neurotransmitters, whereas nicotinic
receptors expressed in the peripheral nervous system are mainly post-synaptic"
SET Confidence = "High"
SET MeSHAnatomy = {"Neurons","Membranes","Central Nervous System"}
a(MESH:"Receptors, Nicotinic") reg tloc(a(CHEBI:neurotransmitter),fromLoc(GO:intracellular),toLoc(GO:"extracellular region"))
UNSET MeSHAnatomy
UNSET Confidence

SET Evidence = "Stimulation of nicotinic receptors present at the CNS presynaptic neuronal membrane
leads to an increase in presynaptic Ca2+ concentration, which
may facilitate the release of a number of neurotransmitters,
such as glutamate, GABA, dopamine, serotonin, norepinephrine, as well as ACh"
SET Confidence = "Medium"
SET MeSHAnatomy = {"Neurons","Membranes","Central Nervous System"}
act(a(MESH:"Receptors, Nicotinic")) -> tloc(a(CHEBI:"calcium(2+)"),fromLoc(GO:"extracellular region"),toLoc(GO:synapse))
UNSET MeSHAnatomy
#MeSHAnatomy looked relevant till the above line and hence was unset
SET MeSHAnatomy = "Synapses"
a(CHEBI:"calcium(2+)") -> tloc(a(CHEBI:"glutamate(2-)"),fromLoc(GO:intracellular),toLoc(GO:"extracellular region"))
a(CHEBI:"calcium(2+)") -> tloc(a(CHEBI:"gamma-aminobutyric acid"),fromLoc(GO:intracellular),toLoc(GO:"extracellular region"))
a(CHEBI:"calcium(2+)") -> tloc(a(CHEBI:dopamine),fromLoc(GO:intracellular),toLoc(GO:"extracellular region"))
a(CHEBI:"calcium(2+)") -> tloc(a(CHEBI:serotonin),fromLoc(GO:intracellular),toLoc(GO:"extracellular region"))
a(CHEBI:"calcium(2+)") -> tloc(a(CHEBI:noradrenaline),fromLoc(GO:intracellular),toLoc(GO:"extracellular region"))
a(CHEBI:"calcium(2+)") -> tloc(a(CHEBI:acetylcholine),fromLoc(GO:intracellular),toLoc(GO:"extracellular region"))
UNSET MeSHAnatomy
UNSET Confidence

SET Evidence = "Thus, ACh can influence the strength and fidelity of various synapses and
modulate overall CNS neurotransmission"
SET Confidence = "High"
SET MeSHAnatomy = "Central Nervous System"
a(CHEBI:acetylcholine) reg bp(MESH:"Synaptic Transmission")
UNSET MeSHAnatomy
UNSET Confidence

SET Evidence = "Agonists of nicotinic ACh receptors can improve, while
antagonists for the receptor impair, performance in cognitive tasks"
SET Confidence = "High"
p(FPLX:CHRN) -> bp(GO:cognition)
UNSET Confidence

SET Evidence = "It has been demonstrated that the role of
ACh in learning and memory seems to be related to the
regulation of glutamatergic neurotransmission"
SET Confidence = "High"
a(CHEBI:acetylcholine) reg bp(GO:"synaptic transmission, glutamatergic")
a(CHEBI:acetylcholine) -- bp(GO:learning)
a(CHEBI:acetylcholine) -- bp(GO:memory)
UNSET Confidence

SET Evidence = "Moreover, the interaction of the cholinergic and glutamatergic
systems seems to be important not only for cognitive
processes but also for neuroprotection, as it has been shown
that nicotinic receptors agonists are neuroprotective in a
mechanism that is Ca2+-dependent and that involves the glutamatergic system"
SET Confidence = "High"
bp(GO:"synaptic transmission, glutamatergic") -- bp(GO:cognition)
bp(GO:"synaptic transmission, glutamatergic") -- path(CONSO:Neurodegeneration)
bp(GO:"synaptic transmission, cholinergic") -- bp(GO:cognition)
bp(GO:"synaptic transmission, cholinergic") -- path(CONSO:Neurodegeneration)
p(FPLX:CHRN) -| path(CONSO:Neurodegeneration)
UNSET Confidence

SET Evidence = "It has been demonstrated that phosphorylation of nicotinic
receptors by protein kinase A, protein kinase C, and tyrosine
kinase can regulate receptor activity"
SET Confidence = "High"
p(FPLX:PKA) -> p(FPLX:CHRN,pmod(Ph))
p(FPLX:PKC) -> p(FPLX:CHRN,pmod(Ph))
a(MESH:"Protein-Tyrosine Kinases") -> p(FPLX:CHRN,pmod(Ph))
p(FPLX:CHRN,pmod(Ph)) reg act(p(FPLX:CHRN))
UNSET Confidence

SET Evidence = "Moreover,nicotinic receptors can also be regulated allosterically by Ca2+"
SET Confidence = "High"
a(CHEBI:"calcium(2+)") reg p(FPLX:CHRN)
UNSET Confidence

SET Evidence = "Not only nicotine, but also DMPP (1,1-Dimethyl-4-
phenylpiperazinium) and cystine can act as nicotinic receptor agonists"
SET Confidence = "High"
complex(p(FPLX:CHRN),a(CHEBI:"1,1-dimethyl-4-phenylpiperazinium iodide")) -> act(p(FPLX:CHRN))
complex(p(FPLX:CHRN),a(CHEBI:cystine)) -> act(p(FPLX:CHRN))
complex(p(FPLX:CHRN),a(CHEBI:nicotine)) -> act(p(FPLX:CHRN))
UNSET Confidence

SET Evidence = "Curare is the best known
antagonist for nicotinic receptors, although this drug is not
capable of blocking central nicotinic receptors"
SET Confidence = "High"
a(CHEBI:tubocurarine) -| act(p(FPLX:CHRN))
UNSET Confidence

SET Evidence = "Muscarinic receptors are G protein coupled receptors that
are capable of modulating a wide variety of ion channels"
SET Confidence = "High"
p(FPLX:CHRM) isA a(MESH:"Receptors, G-Protein-Coupled")
p(FPLX:CHRM) reg a(MESH:"Ion Channels")
UNSET Confidence

SET Evidence = "M1, M3, and M5 are coupled to Gαq, whereas M2 and M4 are coupled to Gαi."
SET Confidence = "High"
complex(p(HGNC:CHRM1),p(INTERPRO:"G-protein alpha subunit, group Q"))
complex(p(HGNC:CHRM3),p(INTERPRO:"G-protein alpha subunit, group Q"))
complex(p(HGNC:CHRM5),p(INTERPRO:"G-protein alpha subunit, group Q"))
complex(p(HGNC:CHRM2),p(INTERPRO:"G-protein alpha subunit, group I"))
complex(p(HGNC:CHRM4),p(INTERPRO:"G-protein alpha subunit, group I"))
UNSET Confidence

SET Evidence = "Stimulation of Gαq coupled muscarinic receptors leads to
activation of phospholipase C and formation of inositol
phosphates and other second messengers, which can promote
closure of K+ channels, thus facilitating cell excitability"
SET Confidence = "High"
complex(p(HGNC:CHRM1),p(INTERPRO:"G-protein alpha subunit, group Q")) -> act(p(FPLX:PLC))
complex(p(HGNC:CHRM1),p(INTERPRO:"G-protein alpha subunit, group Q")) -> a(CHEBI:"myo-inositol")
complex(p(HGNC:CHRM1),p(INTERPRO:"G-protein alpha subunit, group Q")) -| act(a(MESH:"Potassium Channels"))
complex(p(HGNC:CHRM3),p(INTERPRO:"G-protein alpha subunit, group Q")) -> act(p(FPLX:PLC))
complex(p(HGNC:CHRM3),p(INTERPRO:"G-protein alpha subunit, group Q")) -> a(CHEBI:"myo-inositol")
complex(p(HGNC:CHRM3),p(INTERPRO:"G-protein alpha subunit, group Q")) -| act(a(MESH:"Potassium Channels"))
complex(p(HGNC:CHRM5),p(INTERPRO:"G-protein alpha subunit, group Q")) -> act(p(FPLX:PLC))
complex(p(HGNC:CHRM5),p(INTERPRO:"G-protein alpha subunit, group Q")) -> a(CHEBI:"myo-inositol")
complex(p(HGNC:CHRM5),p(INTERPRO:"G-protein alpha subunit, group Q")) -| act(a(MESH:"Potassium Channels"))
UNSET Confidence

SET Evidence = "Activation of Gαi coupled muscarinic receptors
leads to inhibition of adenylyl cyclase and reduction of
cyclic adenosine monophosphate (cAMP) levels, promoting
inhibition of voltage-gated Ca2+ channels and, thus,
diminishing cell excitability"
SET Confidence = "High"
complex(p(HGNC:CHRM2),p(INTERPRO:"G-protein alpha subunit, group I")) -| p(FPLX:ADCY)
complex(p(HGNC:CHRM2),p(INTERPRO:"G-protein alpha subunit, group I")) -| a(CHEBI:"3',5'-cyclic AMP")
complex(p(HGNC:CHRM2),p(INTERPRO:"G-protein alpha subunit, group I")) -| act(a(MESH:"Calcium Channels"))
complex(p(HGNC:CHRM4),p(INTERPRO:"G-protein alpha subunit, group I")) -| p(FPLX:ADCY)
complex(p(HGNC:CHRM4),p(INTERPRO:"G-protein alpha subunit, group I")) -| a(CHEBI:"3',5'-cyclic AMP")
complex(p(HGNC:CHRM4),p(INTERPRO:"G-protein alpha subunit, group I")) -| act(a(MESH:"Calcium Channels"))
UNSET Confidence

SET Evidence = "As a consequence, stimulation
of ACh muscarinic receptors can promote the opening or
closing of Ca2+, K+, or Cl- channels, which might facilitate
either depolarization or hyperpolarization, depending on the
cell type where these receptors are expressed"
SET Confidence = "High"
p(FPLX:CHRM) reg act(a(MESH:"Calcium Channels"))
p(FPLX:CHRM) reg act(a(MESH:"Potassium Channels"))
p(FPLX:CHRM) reg act(a(MESH:"Chloride Channels"))
UNSET Confidence

SET Evidence = "Activation of muscarinic
receptors can block various types of K+ currents by
inhibiting many resting and voltage-gated K+ channels"
SET Confidence = "High"
act(p(FPLX:CHRM)) -| act(a(MESH:"Potassium Channels"))
UNSET Confidence

SET Evidence = "In addition to decreasing K+ currents, muscarinic
receptors located at the presynaptic region can also inhibit GABAergic neurotransmission"
SET Confidence = "High"
act(p(FPLX:CHRM)) -| bp(GO:"synaptic transmission, glutamatergic")
UNSET Confidence

SET Evidence = "On the other hand, stimulation of Gαq coupled muscarinic receptors
generates intracellular second messengers that can facilitate N-methyl-D-aspartate (NMDA) currents"
SET Confidence = "High"
complex(p(HGNC:CHRM1),p(INTERPRO:"G-protein alpha subunit, group Q")) -> a(MESH:"Receptors, N-Methyl-D-Aspartate")
complex(p(HGNC:CHRM3),p(INTERPRO:"G-protein alpha subunit, group Q")) -> a(MESH:"Receptors, N-Methyl-D-Aspartate")
complex(p(HGNC:CHRM5),p(INTERPRO:"G-protein alpha subunit, group Q")) -> a(MESH:"Receptors, N-Methyl-D-Aspartate")
UNSET Confidence

SET Evidence = "The first selective agonist identified for muscarinic
receptors was muscarine and, so far, there is no agonist
available with a specific selectivity for one particular
subtype of muscarinic receptor"
SET Confidence = "High"
complex(a(CHEBI:Muscarine),p(FPLX:CHRM)) -> act(p(FPLX:CHRM))
UNSET Confidence

SET Evidence = "The two best known
muscarinic receptor antagonists are atropine and quinuclidinyl
benzilate, which block all muscarinic receptors"
SET Confidence = "High"
a(CHEBI:atropine) -| act(p(FPLX:CHRM))
a(MESH:"Quinuclidinyl Benzilate") -| act(p(FPLX:CHRM))
UNSET Confidence

SET Evidence = "Because ACh has an important role
in cognitive processes, the cholinergic system is pointed as
an important factor in many forms of dementia, including AD"
SET Confidence = "High"
bp(GO:"synaptic transmission, cholinergic") -- path(MESH:"Alzheimer Disease")
bp(GO:"synaptic transmission, cholinergic") -- path(MESH:Dementia)
a(CHEBI:acetylcholine) --  bp(GO:cognition)
UNSET Confidence

SET Evidence = "Disruption of cholinergic inputs to the cortex can
impair attention and the use of instructive cues needed for
decision-making related to ongoing behavior"
SET Confidence = "High"
bp(GO:"synaptic transmission, cholinergic") -> path(MESH:Attention)
UNSET Confidence

SET Evidence = "Moreover, it has been shown that blocking CA3 cholinergic
receptors impairs the encoding of information and memory"
SET Confidence = "High"
SET MeSHAnatomy = "CA3 Region, Hippocampal"
a(MESH:"Receptors, Cholinergic") -> bp(GO:memory)
UNSET Confidence

SET Evidence = "In addition to cognitive alterations, psychiatric
symptoms are frequently observed in AD patients, including apathy and depression"
SET Confidence = "High"
path(MESH:"Alzheimer Disease") positiveCorrelation path(MESH:Apathy)
path(MESH:"Alzheimer Disease") positiveCorrelation path(MESH:Depression)
path(MESH:"Alzheimer Disease") positiveCorrelation path(MESH:"Cognitive Dysfunction")
UNSET Confidence

SET Evidence = "It has been postulated that the
loss of cholinergic neurons and the consequent impairment
in dopaminergic transmission could be the main factors
underling AD-related psychiatric symptoms"
SET Confidence = "High"
a(MESH:"Cholinergic Neurons") -> bp(GO:"synaptic transmission, dopaminergic")
SET MeSHDisease = "Alzheimer Disease"
a(MESH:"Cholinergic Neurons") -| path(MESH:Apathy)
a(MESH:"Cholinergic Neurons") -| path(MESH:Depression)
UNSET MeSHDisease
UNSET Confidence

SET Evidence = "Corroborating this hypothesis, it has been demonstrated that
dopamine efflux is increased in the nucleus accumbens of M4 knockout mice"
SET Confidence = "High"
SET Species = "10090"
p(MGI:Chrm4) -| tloc(a(CHEBI:dopamine),fromLoc(GO:intracellular),toLoc(GO:"extracellular region"))
UNSET Species
UNSET Confidence

SET Evidence = "Further highlighting the importance of the cholinergic system in the
CNS, cholinergic neuronal loss, especially in the basal
forebrain, occurs not only in AD, but also in Parkinson’s
disease [190, 191], Down syndrome [192], amyotrophic
lateral sclerosis [193, 194], progressive supranuclear palsy
[195, 196], and olivopontocerebellar atrophy [197]"
SET Confidence = "High"
SET MeSHAnatomy = {"Basal Forebrain","Central Nervous System"}
path(MESH:"Alzheimer Disease") negativeCorrelation a(MESH:"Cholinergic Neurons")
path(MESH:"Parkinson Disease") negativeCorrelation a(MESH:"Cholinergic Neurons")
path(MESH:"Down Syndrome") negativeCorrelation a(MESH:"Cholinergic Neurons")
path(MESH:"Amyotrophic Lateral Sclerosis") negativeCorrelation a(MESH:"Cholinergic Neurons")
path(MESH:"Supranuclear Palsy, Progressive") negativeCorrelation a(MESH:"Cholinergic Neurons")
path(MESH:"Olivopontocerebellar Atrophies") negativeCorrelation a(MESH:"Cholinergic Neurons")
UNSET MeSHAnatomy
UNSET Confidence

SET Evidence = "Moreover, Huntington’s disease appears to be associated with decreased ChAT activity"
SET Confidence = "High"
path(MESH:"Huntington Disease") negativeCorrelation act(p(HGNC:CHAT))
UNSET Confidence

SET Evidence = "It has been demonstrated that cholinergic synapses are
particularly affected by Aβ oligomers early neurotoxicity
[218, 219] and that synaptic loss is the major correlate of
cognitive impairment"
SET Confidence = "High"
a(CONSO:"amyloid-beta oligomers") -- act(a(GO:"cholinergic synapse"))
path(MESH:"Cognitive Dysfunction") negativeCorrelation a(GO:synapse)
UNSET Confidence

SET Evidence = "In fact, the memory deficit and neuropathology severity observed in patients exhibiting
AD highly correlate with changes in hippocampal synaptic transmission, especially with changes in
synaptophysin expression, a presynaptic vesicle protein"
SET Confidence = "High"
SET MeSHDisease = "Alzheimer Disease"
SET MeSHAnatomy = "Hippocampus"
bp(MESH:"Synaptic Transmission") -- bp(GO:memory)
p(HGNC:SYP) -- bp(GO:memory)
UNSET MeSHAnatomy
UNSET MeSHDisease
UNSET Confidence

SET Evidence = "The loss of the nucleus basalis cholinergic neurons in AD patients is severe:
from about 500,000 in the healthy adult to less than 100,000
in patients displaying advanced AD"
SET Confidence = "High"
path(MESH:"Alzheimer Disease") negativeCorrelation a(MESH:"Basal Nucleus of Meynert")
UNSET Confidence

SET Evidence = "Moreover, it has
been demonstrated that ChAT transcription is severely
diminished in the remaining cholinergic neurons, which
leads to decreased ChAT activity and progression of dementia"
SET Confidence = "High"
act(p(HGNC:CHAT)) -| path(MESH:Dementia)
path(MESH:"Alzheimer Disease") -| act(p(HGNC:CHAT))
UNSET Confidence

SET Evidence = "All these cholinergic alterations
that take place in AD closely correlates with impaired
attention and memory observed in patients"
SET Confidence = "High"
SET MeSHDisease = "Alzheimer Disease"
a(MESH:"Cholinergic Neurons") -> path(MESH:Attention)
a(MESH:"Cholinergic Neurons") -> bp(GO:memory)
UNSET MeSHDisease
UNSET Confidence

SET Evidence = "Furthermore, some evidences also suggest the involvement
of AChE in the pathogenesis of AD"
SET Confidence = "High"
p(HGNC:ACHE) -- path(MESH:"Alzheimer Disease")
UNSET Confidence

SET Evidence = "A molecular modeling study showed that AChE interacts with the Aβ
peptide and promotes amyloid fibril formation"
SET Confidence = "High"
complex(p(HGNC:ACHE),a(MESH:"Amyloid beta-Peptides")) -> a(CONSO:"amyloid-beta fibrils")
UNSET Confidence

SET Evidence = "In this work, kinetic analyses revealed that a structural motif in AChE (a
hydrophobic sequence of 35 resides peptides) was able to promote amyloid formation and its
incorporation into the growing Aβ-fibrils"
SET Confidence = "High"
p(HGNC:ACHE) -> a(CHEBI:"amyloid-beta")
a(CHEBI:"amyloid-beta") -> a(CONSO:"amyloid-beta fibrils")
UNSET Confidence

SET Evidence = "In addition, quantitative autoradiography assay revealed
that choline uptake was reduced in the hippocampus of these
animals and that the expression of muscarinic and nicotinic
cholinergic receptors was diminished"
SET Confidence = "High"
# these animals: Tg2576 mice
SET Species = "10090"
SET MeSHAnatomy = "Hippocampus"
p(MGI:App,var("?")) -| tloc(a(CHEBI:choline),fromLoc(GO:"extracellular region"),toLoc(GO:intracellular))
p(MGI:App,var("?")) -| p(FPLX:CHRM)
p(MGI:App,var("?")) -| p(FPLX:CHRN)
UNSET Species
UNSET MeSHAnatomy
UNSET Confidence



SET Evidence = "Cholinesterase inhibitors can increase ACh levels in the
synaptic cleft and partially ameliorate cognitive symptoms,
enhance quality of life and diminish caregiver burden for
patients with mild to severe AD"
SET Confidence = "High"
SET MeSHDisease = "Alzheimer Disease"
# in the synaptic cleft
a(MESH:"Cholinesterase Inhibitors") -> a(CHEBI:acetylcholine)
a(MESH:"Cholinesterase Inhibitors") -> bp(GO:cognition)
UNSET Confidence

SET Evidence = "It has been demonstrated that treatment with donepezil
is associated with significant cognitive and functional
benefits over the course of 12 months in patients with
moderate to severe AD"
SET Confidence = "High"
a(CHEBI:donepezil) -> bp(GO:cognition)
UNSET Confidence

SET Evidence = "In a double-blind study
designed to assess patients survival with mild to moderately
severe AD, the long-term treatment (2 years) with galantamine
significantly reduced mortality and cognition decline,
besides improving daily live activities in mild to moderate AD patients"
SET Confidence = "High"
a(CHEBI:galanthamine) -| path(MESH:Death)
a(CHEBI:galanthamine) -> bp(GO:cognition)
UNSET Confidence

SET Evidence = "Rivastigmine has also been used for AD
treatment due to its ease of use (transdermal patch) and good
tolerability by patients"
SET Confidence = "High"
a(CHEBI:rivastigmine) negativeCorrelation path(MESH:"Alzheimer Disease")
UNSET Confidence

SET Evidence = "It has been demonstrated that M1 muscarinic
receptors coupling to G-proteins is impaired in the neocortex
of AD patients and that the extent of M1/G-protein
uncoupling is related to the severity of cognitive symptoms in AD"
SET Confidence = "High"
SET MeSHAnatomy = "Neocortex"
path(MESH:"Alzheimer Disease") negativeCorrelation complex(p(HGNC:CHRM1),p(INTERPRO:"G-protein alpha subunit, group Q"))
complex(p(HGNC:CHRM1),p(INTERPRO:"G-protein alpha subunit, group Q")) -> bp(GO:cognition)
UNSET MeSHAnatomy
UNSET Confidence

SET Evidence = "Interestingly, M1 receptor signaling affects several of AD major hallmarks,
including cholinergic deficit, cognitive dysfunction, and tau and Aβ pathologies"
SET Confidence = "High"
act(p(HGNC:CHRM1)) -- a(MESH:"Cholinergic Neurons")
act(p(HGNC:CHRM1)) -- path(MESH:"Cognitive Dysfunction")
act(p(HGNC:CHRM1)) -- act(p(HGNC:MAPT))
act(p(HGNC:CHRM1)) -- act(a(CHEBI:"amyloid-beta"))
UNSET Confidence

SET Evidence = "It has been shown that activation
of M1 receptors decreases tau hyperphosphorylation via
activation of PKC and inhibition of GSK-3β"
SET Confidence = "High"
act(p(HGNC:CHRM1)) -| p(HGNC:MAPT,pmod(CONSO:hyperphosphorylation))
act(p(HGNC:CHRM1)) -> act(p(FPLX:PKC))
act(p(HGNC:CHRM1)) -| act(p(HGNC:GSK3B))
UNSET Confidence

SET Evidence = "Moreover, the M1 agonist AF267B can rescue the cognitive
impairment and decrease Aβ42 and tau abnormalities in the
cortex and hippocampus of a mouse model of AD"
SET Confidence = "High"
SET MeSHAnatomy = {"Hippocampus","Neocortex"}
a(PUBCHEM:10013505) -> act(p(HGNC:CHRM1))
a(PUBCHEM:10013505) -> bp(GO:cognition)
a(PUBCHEM:10013505) -| a(CHEBI:"amyloid-beta polypeptide 42")
a(PUBCHEM:10013505) -| p(HGNC:MAPT,var("?"))
UNSET MeSHAnatomy
UNSET Confidence

SET Evidence = "Moreover, AF267B treatment leads to an increase in alpha
secretase, which is an enzyme that can prevent the production of Aβ peptide"
SET Confidence = "High"
a(PUBCHEM:10013505) -> a(MESH:"Amyloid Precursor Protein Secretases")
a(MESH:"Amyloid Precursor Protein Secretases") -| a(MESH:"Amyloid beta-Peptides")
UNSET Confidence

SET Evidence = "Moreover, the use of M2 antagonists, such as SCH-57790 and SC-72788, can lead to
blockage of M2-mediated inhibition of presynaptic release of ACh, which can activate M1 and nicotinic receptors,
ameliorating cognitive impairment in AD"
SET Confidence = "High"
a(PUBCHEM:9867750) -> tloc(a(CHEBI:acetylcholine),fromLoc(GO:intracellular),toLoc(GO:"extracellular region"))
p(HGNC:CHRM2) -| tloc(a(CHEBI:acetylcholine),fromLoc(GO:intracellular),toLoc(GO:"extracellular region"))
a(PUBCHEM:9867750) -> act(p(HGNC:CHRM1))
a(PUBCHEM:9867750) -> act(a(MESH:"Receptors, Nicotinic"))
a(PUBCHEM:9867750) -> bp(GO:cognition)
UNSET Confidence

SET Evidence = "In addition, activation of M2 receptors can cause an increase in Aβ production"
SET Confidence = "High"
act(p(HGNC:CHRM2)) -> a(CHEBI:"amyloid-beta")
UNSET Confidence

SET Evidence = "However, further studies have
demonstrated that nicotinic receptor activation can lead to an
increase in Aβ-mediated tau phosphorylation"
SET Confidence = "High"
act(a(MESH:"Receptors, Nicotinic")) -> p(HGNC:MAPT,pmod(Ph))
a(CHEBI:"amyloid-beta") reg p(HGNC:MAPT,pmod(Ph))
UNSET Confidence

SET Evidence = "In a large-scale placebo-controlled clinical trial, it was
demonstrated that xanomeline, a muscarinic agonist with
reasonable selectivity for M1/M4 receptors, exhibits a
positive effect in minimizing, in a dose-dependent manner,
cognitive and psychiatric symptoms in AD, including memory
deficit, mood disturbance, agitation and hallucinations"
SET Confidence = "High"
a(CHEBI:xanomeline) -> bp(GO:cognition)
a(CHEBI:xanomeline) -> bp(GO:memory)
a(CHEBI:xanomeline) -| path(MESH:"Mood Disorders")
a(CHEBI:xanomeline) -| path(MESH:"Psychomotor Agitation")
a(CHEBI:xanomeline) -| path(MESH:Hallucinations)
UNSET Confidence

SET Evidence = "For example, it has been shown that the benzyl
quinolone carboxylic acid (BQCA), which is an M1-selective
allosteric agonist, is effective in increasing spontaneous
excitatory postsynaptic currents in the medial prefrontal
cortex (mPFC) pyramidal cells and improving memory in a
transgenic mouse model of AD"
SET Confidence = "High"
SET MeSHAnatomy = "Pyramidal Cells"
a(PUBCHEM:1476756) -> bp(GO:"excitatory postsynaptic potential")
a(PUBCHEM:1476756) -> bp(GO:memory)
UNSET MeSHAnatomy
UNSET Confidence

SET Evidence = "In fact, it has been shown that APP interacts
with CHT1 proteins increasing their endocytosis from the cell surface [258] and that mice that display disruption of
CHT1 gene expression exhibit symptoms related to ACh deficit"
SET Confidence = "High"
complex(p(HGNC:APP),p(HGNC:SLC5A7)) -> tloc(p(HGNC:APP),fromLoc(GO:"cell surface"),toLoc(GO:intracellular))
UNSET Confidence

SET Evidence = "In fact, memantine is able to reduce the excitotoxicity in AD"
SET Confidence = "High"
a(CHEBI:memantine) -| path(CONSO:Excitotoxicity)
UNSET MeSHDisease
UNSET Confidence

SET Evidence = "Furthermore, it has also been
proposed that the nerve growth factor (NGF) has the
potential to preserve cholinergic neurons"
SET Confidence = "High"
a(MESH:"Nerve Growth Factor") -> a(MESH:"Cholinergic Neurons")
UNSET Confidence

SET Evidence = "Moreover, previous studies have shown that treatment
with NGF can counteract cholinergic atrophy and memory
deficits in aged rats"
SET Confidence = "High"
a(MESH:"Nerve Growth Factor") -> a(MESH:"Cholinergic Neurons")
a(MESH:"Nerve Growth Factor") -> bp(GO:memory)
UNSET Confidence
